Skip to content

Phase 1 open label trial of MST-0312 alone and in combination in subjects with solid malignancies

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524446-10-00
Enrollment
42
Registered
2026-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Malignancies

Interventions

None listed

Sponsors

Mestag Therapeutics Limited
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Mar 14, 2026